METHODS AND COMPOSITIONS FOR INACTIVATION OF DIHYDROFOLATE REDUCTASE
    2.
    发明申请
    METHODS AND COMPOSITIONS FOR INACTIVATION OF DIHYDROFOLATE REDUCTASE 审中-公开
    二氢叶酸还原酶灭活的方法和组合物

    公开(公告)号:WO2007136685A3

    公开(公告)日:2008-05-22

    申请号:PCT/US2007011799

    申请日:2007-05-17

    CPC classification number: C12N15/62 A61K48/00 C12N9/22

    Abstract: Disclosed herein are methods and compositions for inactivating dihydrofolate reductase genes, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.

    Abstract translation: 本文公开了使用包含锌指蛋白和切割结构域或裂解半结构域的融合蛋白来灭活二氢叶酸还原酶基因的方法和组合物。 还提供了编码所述融合蛋白的多核苷酸,以及包含所述多核苷酸和融合蛋白的细胞。

    METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN
    3.
    发明申请
    METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN 审中-公开
    治疗神经性疼痛的方法和组合

    公开(公告)号:WO2005118614A1

    公开(公告)日:2005-12-15

    申请号:PCT/US2005/012048

    申请日:2005-04-08

    CPC classification number: C07K14/4703 A61K38/00

    Abstract: Compositions and methods for the treatment of neuropathic pain are provided. Compositions of the invention may comprise proteins with a zinc-finger domain fused to a regulatory domain that is capable of either activating or repressing the expression of a target gene involved in neuropathic pain. Alternatively, compositions of the invention may comprise a nucleic acid sequence encoding a protein of the invention, which nucleic acid sequence may optionally be provided as a plasmid or within a virus or other vector for delivery to a target cell or tissue. Methods of treating neuropathic pain involving treatment of subject with the compositions of the invention are also provided. Exemplary target genes for the treatment of neuropathic pain include VR1, NaV1.8, and TrkA.

    Abstract translation: 提供了治疗神经性疼痛的组合物和方法。 本发明的组合物可以包含具有融合到调节结构域的锌指结构域的蛋白质,其能够激活或抑制涉及神经性疼痛的靶基因的表达。 或者,本发明的组合物可以包含编码本发明的蛋白质的核酸序列,该核酸序列可以任选地作为质粒提供,或者在病毒或其它载体内提供用于递送至靶细胞或组织。 还提供了使用本发明的组合物治疗涉及受试者的神经性疼痛的方法。 用于治疗神经性疼痛的示例性靶基因包括VR1,NaV1.8和TrkA。

    METHODS AND COMPOSITIONS FOR INACTIVATION OF DIHYDROFOLATE REDUCTASE
    5.
    发明申请
    METHODS AND COMPOSITIONS FOR INACTIVATION OF DIHYDROFOLATE REDUCTASE 审中-公开
    二氢叶酸还原酶灭活的方法和组合物

    公开(公告)号:WO2007136685A2

    公开(公告)日:2007-11-29

    申请号:PCT/US2007/011799

    申请日:2007-05-17

    CPC classification number: C12N15/62 A61K48/00 C12N9/22

    Abstract: Disclosed herein are methods and compositions for inactivating dihydrofolate reductase genes, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.

    Abstract translation: 本文公开了使用包含锌指蛋白和切割结构域或裂解半结构域的融合蛋白来灭活二氢叶酸还原酶基因的方法和组合物。 还提供了编码所述融合蛋白的多核苷酸,以及包含所述多核苷酸和融合蛋白的细胞。

Patent Agency Ranking